The microbiome in post-acute infection syndrome (PAIS)

[1]  J. Montoya,et al.  A multicenter virome analysis of blood, feces, and saliva in myalgic encephalomyelitis/chronic fatigue syndrome , 2023, Journal of Medical Virology.

[2]  Meera K. Jairath,et al.  Treatment of Long-Haul COVID Patients With Off-Label Acyclovir , 2023, Cureus.

[3]  T. Henrich,et al.  Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) , 2023, eLife.

[4]  Yan Xie,et al.  Long-term gastrointestinal outcomes of COVID-19 , 2023, Nature Communications.

[5]  J. Penninger,et al.  Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic , 2023, Cell.

[6]  S. Vernon,et al.  Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients. , 2023, Cell host & microbe.

[7]  A. Komaroff,et al.  Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS , 2023, Cell host & microbe.

[8]  E. Topol,et al.  Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.

[9]  S. Candel,et al.  The nasopharyngeal microbiome in COVID-19 , 2023, Emerging microbes & infections.

[10]  David M. Liebovitz,et al.  Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up , 2022, medRxiv.

[11]  G. Réus,et al.  The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature , 2022, Frontiers in Cellular and Infection Microbiology.

[12]  A. Kuzovlev,et al.  Bacteriophage Cocktails in the Post-COVID Rehabilitation , 2022, Viruses.

[13]  S. Park,et al.  Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases , 2022, BMC Microbiology.

[14]  Ashwag R. Alruwaili,et al.  Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications , 2022, Metabolites.

[15]  M. Peluso,et al.  Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling , 2022, JCI insight.

[16]  B. Owens.  How “long covid” is shedding light on postviral syndromes , 2022, BMJ.

[17]  E. Waltz.  Could long COVID be linked to herpes viruses? Early data offer a hint. , 2022, Nature.

[18]  C. D. Dela Cruz,et al.  Distinguishing features of long COVID identified through immune profiling , 2022, Nature.

[19]  G. Gkoutos,et al.  Symptoms and risk factors for long COVID in non-hospitalized adults , 2022, Nature Medicine.

[20]  M. Peluso,et al.  Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling , 2022, JCI insight.

[21]  Zu-Jiang Yu,et al.  Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up , 2022, Military Medical Research.

[22]  P. Wilairatana,et al.  Abnormal Blood Bacteriome, Gut Dysbiosis, and Progression to Severe Dengue Disease , 2022, Frontiers in Cellular and Infection Microbiology.

[23]  V. Chopyak,et al.  Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study , 2022, Rheumatology International.

[24]  W. Tate,et al.  Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses , 2022, Frontiers in Neurology.

[25]  M. Girardis,et al.  Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality , 2022, Intensive Care Medicine.

[26]  A. Iwasaki,et al.  Unexplained post-acute infection syndromes , 2022, Nature Medicine.

[27]  Ainsley Lockhart,et al.  Immunity to enteric viruses. , 2022, Immunity.

[28]  S. Cristoni,et al.  Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? , 2022, Vaccines.

[29]  N. Thomas,et al.  The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome , 2022, Frontiers in Neuroendocrinology.

[30]  Guojun Wu,et al.  Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome , 2022, mBio.

[31]  R. Lamont,et al.  Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma. , 2022, Periodontology 2000.

[32]  G. Muscogiuri,et al.  Dietary Recommendations for Post-COVID-19 Syndrome , 2022, Nutrients.

[33]  T. Clark,et al.  A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2022, Frontiers in Medicine.

[34]  A. Hay,et al.  Respiratory tract infections and gut microbiome modifications: A systematic review , 2022, PloS one.

[35]  Jordi Espadaler Mazo,et al.  Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial , 2022, Gut microbes.

[36]  P. Vernazza,et al.  The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) , 2022, Frontiers in Immunology.

[37]  S. Ng,et al.  Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome , 2022, Gut.

[38]  R. Guy,et al.  Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England , 2022, Journal of Infection.

[39]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[40]  E. Hsiao,et al.  Signaling inflammation across the gut-brain axis , 2021, Science.

[41]  A. Chater,et al.  The Influence of a blend of Probiotic Lactobacillus and Prebiotic Inulin on the Duration and Severity of Symptoms among Individuals with Covid-19 , 2021, Infectious Diseases Diagnosis & Treatment.

[42]  F. Bai,et al.  Female gender is associated with long COVID syndrome: a prospective cohort study , 2021, Clinical Microbiology and Infection.

[43]  G. Ricevuti,et al.  The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications , 2021, Journal of clinical medicine.

[44]  A. Barać,et al.  Microbiota and viral hepatitis: State of the art of a complex matter , 2021, World journal of gastroenterology.

[45]  V. Bucci,et al.  Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID , 2021, JCI insight.

[46]  Jianchu Zhang,et al.  Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge , 2021, Journal of Microbiology.

[47]  Cheng Guo,et al.  Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization , 2021, NPJ biofilms and microbiomes.

[48]  Wancun Zhang,et al.  Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis , 2021, Heliyon.

[49]  A. Peres,et al.  Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients , 2021, International Immunopharmacology.

[50]  A. Komaroff,et al.  Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome , 2021, Trends in Molecular Medicine.

[51]  D. Hurley,et al.  Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation , 2021, Pathogens.

[52]  L. Appel,et al.  Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial , 2021, Diabetes Care.

[53]  Jiaqi Wang,et al.  Microbiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics , 2021, Frontiers in Nutrition.

[54]  Lanjuan Li,et al.  Six-month follow-up of gut microbiota richness in patients with COVID-19 , 2021, Gut.

[55]  Zhihua Li,et al.  Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment , 2021, Antimicrobial Resistance & Infection Control.

[56]  P. Formenty,et al.  Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors , 2021, PLoS medicine.

[57]  M. Baldridge,et al.  The Complex Interactions Between Rotavirus and the Gut Microbiota , 2021, Frontiers in Cellular and Infection Microbiology.

[58]  C. Jobin,et al.  The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort , 2021, Gut microbes.

[59]  Xuedong Zhou,et al.  Potential implications of SARS-CoV-2 oral infection in the host microbiota , 2020, Journal of oral microbiology.

[60]  J. Simmons,et al.  The gut microbiota in anxiety and depression - A systematic review. , 2020, Clinical psychology review.

[61]  Alison W. Rebman,et al.  A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients , 2020, mBio.

[62]  L. Ye,et al.  Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation , 2020, Frontiers in Cellular and Infection Microbiology.

[63]  A. Malhotra,et al.  ACE2, Metformin, and COVID-19 , 2020, iScience.

[64]  Marcelo Cicconet,et al.  Neurons that regulate mouse torpor , 2020, Nature.

[65]  Lanjuan Li,et al.  Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  E. Elinav,et al.  Interaction between microbiota and immunity in health and disease , 2020, Cell Research.

[67]  S. Ng,et al.  Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization , 2020, Gastroenterology.

[68]  R. Omdal.  The biological basis of chronic fatigue: neuroinflammation and innate immunity. , 2020, Current opinion in neurology.

[69]  H. Shan,et al.  Prolonged presence of SARS-CoV-2 viral RNA in faecal samples , 2020, The Lancet Gastroenterology & Hepatology.

[70]  G. Milligan,et al.  Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production. , 2020, Cell reports.

[71]  Amelia T. Soderholm,et al.  Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity , 2019, Immunology.

[72]  H. Izadi,et al.  A retrospective outcome study of 42 patients with Chronic Fatigue Syndrome, 30 of whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation , 2019, Human Microbiome Journal.

[73]  S. Schultz-Cherry,et al.  Astrovirus and the microbiome. , 2019, Current opinion in virology.

[74]  M. Moffatt,et al.  Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence , 2019, mBio.

[75]  A. Horswill,et al.  Regulation of Staphylococcus aureus Virulence , 2019, Microbiology spectrum.

[76]  Jeremy J. Barr,et al.  Phage Therapy in the Postantibiotic Era , 2019, Clinical Microbiology Reviews.

[77]  V. Young,et al.  The role of the microbiota in infectious diseases , 2018, Nature Microbiology.

[78]  T. Marshall,et al.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity , 2018, Front. Pediatr..

[79]  N. Bhala,et al.  The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines , 2018, Gut.

[80]  G. Rørtveit,et al.  Prevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[81]  K. Schughart,et al.  Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function , 2018, The Journal of Neuroscience.

[82]  D. Staines,et al.  A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) , 2018, Probiotics and Antimicrobial Proteins.

[83]  M. Schmolke,et al.  Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis , 2018, Microbiome.

[84]  J. Clemente,et al.  The role of the gut microbiome in systemic inflammatory disease , 2018, British Medical Journal.

[85]  S. Yeh,et al.  An update on ocular complications of Ebola virus disease , 2017, Current opinion in ophthalmology.

[86]  S. Mazmanian,et al.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. , 2017, Immunity.

[87]  A. Perelson,et al.  Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys , 2017, Cell.

[88]  A. Komaroff,et al.  Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome , 2017, Microbiome.

[89]  J. Clemente,et al.  The microbiome in early life: implications for health outcomes , 2016, Nature Medicine.

[90]  A. Rodríguez-Morales,et al.  Prevalence of Post‐Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta‐Analysis , 2016, Arthritis care & research.

[91]  Stephanie M. Karst.  The influence of commensal bacteria on infection with enteric viruses , 2016, Nature Reviews Microbiology.

[92]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[93]  M. Mego,et al.  Confirmation of HIV-like sequences in respiratory tract bacteria of Cambodian and Kenyan HIV-positive pediatric patients , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[94]  J. Chia,et al.  The role of enterovirus in chronic fatigue syndrome , 2005, Journal of Clinical Pathology.

[95]  B. Jubelt,et al.  Characteristics and management of postpolio syndrome. , 2000, JAMA.

[96]  L. Aliste,et al.  Gender differences in chronic fatigue syndrome. , 2016, Reumatologia clinica.

[97]  S. Ciernikova,et al.  Testing of bacteria isolated from HIV/AIDS patients in experimental models. , 2006, Neuro - endocrinology letters.

[98]  V. Zhdanov,et al.  [Enteric viruses]. , 1958, Voprosy virusologii.